Benign Prostatic Hyperplasia PEMF

This PTL protocol fits within a male prostate-focused targeting framework, with particular attention to benign prostatic enlargement. The tissue channel directly targets the prostate and the prostatic plexus, giving the protocol anatomical coherence. The support channel combines axes related to inflammation, vitality, congestion, toxicity, and certain infectious or parasitic burdens. A few secondary frequencies cautiously broaden the support toward emotional balance, older tissue patterns, or calculus-related phenomena.